Skip to main content
101 results:
1. Lightning  
The sphingotest® Lightning is a reagent intended for quantitative in vitro diagnostics and used for automated chemiluminescence measurement of sphingotest® immunoluminometric assays (ILMA) using…  
2. DPP3  
The sphingotest® DPP3 is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of dipeptidyl peptidase 3 in human EDTA plasma. Dipeptidyl peptidase…  
3. bio-ADM  
The sphingotest® bio-ADM® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma. Bioactive…  
4. penKid  
sphingotest® penKid® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of Proenkephalin A 119-159 in human EDTA plasma. Proenkephalin A 119-159…  
5. Team  
Our skilled international team has a breadth of experience in life sciences, disease biology, biotechnology, and clinical in vitro diagnostics and is dedicated to supporting the medical community and…  
6. www.sphingotec.com  
Follow our Journey on Social Media View all Events View all News Events & Expos Latest News Subscribe to our Newsletter Follow the link below to subscribe to our…  
7. Clinical Evaluation  
With the mission of improving patient management in critical care settings, SphingoTec has started a series of collaboration with internationally leading academic and non-academic medical centers.  
8. New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients  
A new, improved formula has been developed for estimating the GFR using kidney function biomarker penKid. According to the data, penKid strongly correlates with the measured GFR (mGFR), while the…  
9. International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools  
A new study and real-world data on the kidney function biomarker penKid underline its potential to monitor kidney function during acute kidney injury (AKI) and RRT and to support liberation decisions…  
10. Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid  
The MDA solidifies the partnership between Boditech and SphingoTec, aiming to support the successful commercialization of the assay for the biomarker penKid on the AFIAS platforms.  
Search results 1 until 10 of 101